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Abstract
Sarcopenia is a complex problem and an important emerging field in rehabilitation of the 
elderly. In 2010, the European working group on sarcopenia in older people (EWGSOP) 
described sarcopenia as a syndrome characterised by progressive and generalised loss 
of skeletal muscle mass and strength, associated with a risk of adverse outcomes such 
as physical disability, poor quality of life and death. This field of rehabilitation has been 
defined as ‘evaluative, diagnostic and therapeutic interventions whose purpose is to 
restore functional ability or enhance residual functional capability in elderly people with 
disabling impairments’. With growing numbers of frail older people, there is an increas-
ing need for appropriate geriatric rehabilitation services. Definitely, sarcopenia needs a 
specific rehabilitation program to improve muscular mass and strength that must be inte-
grated with a global approach with the aim to recover postural assessment, amplify sen-
sory‐motor systems, in order to gain the necessary information for proper motor planning, 
to reduce risk of falls. Several physical agents in medicine permit to treat sarcopenia, like 
vibrations or electrical stimulation. The aim of this chapter is to give an overview about 
rehabilitative medicine for sarcopenia, highlighting the state of the art, presenting the most 
significative clinical researches and giving some inputs to set a rehabilitation protocol.
Keywords: sarcopenia, physical energies, complex sensory‐motor rehabilitation 
program, vibrations, electrical stimulation
1. Introduction
Sarcopenia (from the Greek sarx ‘flesh’ and penia ‘loss’) is a term used for the first time by 
Rosenberg to describe the age‐related decrease in muscle mass. In fact, aging is associated with 
a progressive decline in muscle mass that can lead to a decrease in muscle quality and strength. 
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
In 2010, the European working group on sarcopenia in older people (EWGSOP) described sar-
copenia as a syndrome characterised by progressive and generalised loss of skeletal muscle 
mass and strength, associated with a risk of adverse outcomes such as physical disability, poor 
quality of life and death [1]. The reduction in muscle mass is associated with longer hospi-
talisation, increased need for rehabilitation care after hospital discharge, infective complica-
tions, prolonged duration of mechanical ventilation and higher mortality. There are several 
approaches to treat sarcopenia and it was demonstrated that, regardless of the type of interven-
tion, treatment improves the quality of life preventing falls, disability and loss of independence 
among elderly patients [2]. Among interventions, resistance training has been shown to be the 
most effective to reduce the effects of sarcopenia, this because it induces skeletal muscle hyper-
trophy and enhances muscle strength; unfortunately, resistance training is not always feasible 
in sarcopenic elderly people [2]. Therefore, in these cases, physical therapies come to the res-
cue, i.e. vibrations or electrical stimulations. Particularly, it is possible to use focal vibrations, 
which excite the afferents coming from the neuromuscular spindle, leading to the activation 
of the proprioceptive sensory system. Electrical stimulation too is an alternative, even more 
effective than exercise alone, in strengthening muscles in sarcopenic patients [3]. These alter-
native approaches to exercise offered a safe addition to a traditional, high‐intensity volitional 
strengthening program with the aim to implement muscular mass and strength. It is also a nec-
essary adequate sensory‐motor and functional recovery program to reach an acceptable walk-
ing ability. The ability to walk is the key to any human movement, despite the fact the human 
movements are not limited to bipedal locomotion; bipedal locomotion is a fundamental part 
of daily life and is a prominent target of public health physical activity guidelines [4]. In order 
to get a better walking performance and a postural global improvement, two integrate pro-
cedures may be used: normalisation of the foot‐ground reaction to control vertical and shear 
forces on the foot during the stance phase; second one is the microgravitary environment that 
determines the sensory‐motor and functional recovery of the posture during walking activity 
in combination to the development of proprioceptive information from periphery to the corti-
cal central system [4]. Definitely, sarcopenia needs a specific rehabilitation program to improve 
muscular mass and strength that must be integrated with a global approach with the aim to 
recovery postural assessment, amplify sensory‐motor systems, in order to gain the necessary 
information for proper motor planning, to reduce risk of falls.
2. Background
Aging, as mentioned, is characterised by a progressive loss of skeletal muscle mass and 
strength, thus leading to the loss of functional capacity. In sarcopenia, the loss of skeletal 
muscle mass must be due to a chronic disruption in the balance between muscle protein syn-
thesis and degradation.
In active and healthy elderly patients, the mechanism underlying the loss of muscle mass does 
not seem to be bound to a disorder of protein metabolism in the basal state (fasting). Rather, it 
was proposed that muscle in the elderly presents a deficiency in the ability to regulate protein 
synthesis in response to an anabolic stimulus, such as physical activity or food intake [1].
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According to epidemiological data in literature, the prevalence of sarcopenia in people rang-
ing in ages from 60 to 70 turns out to be 5–13%, while in patients over 80, it varies between 
11 and 50% [2]. In 2000, the number of people worldwide over the age of 60 years was esti-
mated at 600 million, a value that is forecast to rise to 1.2 billion in 2025 and 2 billion in 2050 
[5]. Making an approximate estimate about the prevalence, people with sarcopenia nowa-
days are more than 50 million that should increase to over 200 million in the next 40 years.
The impact of sarcopenia in elderly affects multiple aspects; in fact, its influence can be seen in 
terms of morbidity [6], disability [7], increasing in costs related to health care [8] and mortality [9].
The underlying causes of sarcopenia and frailty are multifactorial. Although the progressive 
loss of muscle mass that occurs with aging is well‐known for many years, but it is only with 
the latest techniques and prospective‐longitudinal studies that changes related to aging in 
muscle composition have begun to be described [10].
Several reviews have highlighted cellular and molecular mechanisms underlying the weak-
ness and muscle atrophy related to aging [11]. It has been seen that the loss of muscle strength 
and mass are the consequence of a progressive atrophy due to a loss of individual muscle 
fibres associated to a reduction of some motor units; this implies fat and other non‐contractile 
tissue (i.e. fibrous tissue) infiltrations which involves a reduction of ‘muscle quality’ [1].
Therefore, changes in musculoskeletal age are initially neuromuscular and subsequently oth-
ers several factors intervene (Figure 1) such as neural transmission, protein synthesis and 
Figure 1. Factors that affect the muscle maintenance and/or the onset of sarcopenia. + positive influence, − negative influence. 
GH growth hormone, IGF‐1 insulin‐like growth factor 1, HGF: hepatocyte growth factor, FGF: fibroblast growth factor.
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degradation, muscle architecture, composition of muscle fibres, increasing in production of 
reactive oxygen species, apoptosis of muscle cells, alteration in excitation‐contraction cou-
pling and metabolism [11].
In generic terms, sarcopenia is the age‐associated loss of skeletal muscle mass and function; this 
decline is progressive and generalised with the possible risk of adverse outcomes such as phys-
ical disability, poor quality of life and even death [12, 13]. The causes are multifactorial and can 
include disuse, changing endocrine function, chronic diseases, inflammation, insulin resistance 
and nutritional deficiencies. The pathogenic mechanisms underlying sarcopenia are different 
from acute muscular atrophy resulting from disuse, cachexia, denervation or other conditions.
In order to make the diagnosis of sarcopenia, the European working group on sarcopenia in 
older people (EWGSOP) recommends verifying the simultaneous presence of both low mus-
cle mass and reduction in muscle function (understood as strength or performance). Thus, the 
diagnosis requires the satisfaction of the criterion 1 in combination of criterion 2 or criterion 3 
(Table 1).
The reason why are necessary at least two criteria for the diagnosis is that the force does not 
depend only on the muscle mass and also the relationship between strength and mass is not 
linear [14]. In fact, alterations in muscle quality have a central role in the loss of strength in 
elderly. Hughes et al. [15] showed that only a variation of 5% in strength depends on muscle 
mass. Muscle weakness may lead to reduced function, decreased physical activity and immobil-
ity, thus leading to secondary muscular ‘ex non usu’ atrophy. Consequently, diminished muscle 
mass is the result, but also the cause of age‐related loss of strength. This is due to increased 
levels of pro‐inflammatory cytokines and to a damage of type 2 muscle fibres. Furthermore, 
the growth in muscle mass is not directly related to an increment in strength, which may be 
increased even in the absence of a visible variation of muscle mass [16]. Neurological changes, 
hormonal and metabolic milieu, pro‐inflammatory cytokines, fat infiltration (lipotoxicity) may 
conduce to a progressive muscle weakness in elderly [13]. Therefore, defining sarcopenia only in 
terms of loss of muscle mass is too simplistic and may be of limited clinical value. Precisely for 
this reason, some authors argue that the term dynapenia would be preferable to describe the loss 
of strength and function associated with aging [17]. However, ‘sarcopenia’ is a term so widely 
spread that replacing it could generate more confusion.
Sarcopenia staging, which reflects the severity degree of the disease, is a concept that can be 
of assistance in clinical management of the condition; specifically, the EWGSOP suggests a 
division into ‘pre‐sarcopenia’, ‘sarcopenia’ and ‘severe sarcopenia’ (Table 2). ‘Pre‐sarcopenia’ 
stage is characterised by low muscle mass without influencing on muscle strength or  physical 
Diagnosis is based on documentation of criterion 1 plus criterion 2 or 3
1. Low muscle mass
2. Low muscle strength
3. Low physical performance
Table 1. EWGSOP diagnostic criteria.
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performance; this phase can only be identified by techniques that measure muscle mass accu-
rately (see later). Concerning to standard populations, ‘sarcopenia’ stage is characterised by 
low muscle mass with low muscle strength or low physical performance. The last stage, when 
the three criteria (low muscle mass, low muscle strength and low physical performance) are 
present concomitantly, is defined as ‘severe sarcopenia’. Recognising different stages of sar-
copenia is essential to choose the most appropriate treatment and setting, thus enabling the 
achievement of therapeutic goals. Staging also allows to program scientific research focused 
on a particular stage or to evaluate any changes over time [18].
Generally, all the syndromes associated with prominent muscle loss are described as sarco-
penia. Only research on the etiopathological mechanisms of age‐related sarcopenia can lead 
to distinction from secondary forms, so the most appropriate therapy for each of them can be 
chosen such as cachexia, frailty and sarcopenic obesity.
The parameters of sarcopenia are muscle mass and function. The measurable variables are 
mass, strength and physical performance; for diagnostic and research purposes, it is important 
to identify the best diagnostic test that is able to measure them accurately. It is also important 
to recognise changes by repeating the same measures over time in the same individuals [18].
Only a few clinical trials are underway to evaluate the potential for sarcopenia treatments 
compared to the great impact that reduced mobility and functionality have on the quality of 
life of older people. The absence of standardised primary outcomes is a major challenge for 
the design of such studies. For intervention trials, EWGSOP presently recommends three pri-
mary outcome variables: muscle mass, muscle strength and physical performance (Table 3). 
Further studies could lead to the finding of outcomes currently considered secondary, but 
which may play a central role in the diagnostic and prognostic phase of this clinical condition.
Among methods of evaluation computed tomography (CT) and magnetic resonance imaging 
(MRI) can distinguish fat from other soft tissues of the body, thus representing validate meth-
ods for estimating muscle mass for research scope. The high costs and risks related to exposure 
to radiation (TC), limit their use in clinical practice. Dual energy X‐ray absorptiometry (DEXA) 
distinguishes adipose tissue, bone mineral mass and lean body mass. It can be used both in 
research and in clinical practice and exposes patients to a smaller quantity of radiations. 
However, the access to this method is limited for severely obese individuals; furthermore, 
the equipment is not portable, which limits its use in epidemiological studies on a large scale.
Bioimpedance analysis (BIA) is a test that is not expensive, easy to use, easily reproducible and 
suitable for both ambulatory patients and bedridden. The bioelectrical impedance  measurement 
Stage Muscle mass Muscle strength Performance
Pre‐sarcopenia ↓
Sarcopenia ↓ ↓ Or ↓
Severe sarcopenia ↓ ↓ ↓
Table 2. EWGSOP stages of sarcopenia.
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techniques have been studied for many years and the BIA results in standard conditions cor-
relate with the predictions of the MRI [19].
Among measurements to assess muscle strength, it is necessary to emphasise the importance 
of handgrip test; even if lower limbs are more relevant than the upper limbs in physical func-
tion and walking, the evaluation of strength by isometric handgrip has been widely used. 
Measured under standard conditions, with a well‐studied model of dynamometer hand, it is 
closely correlated with lower limb muscles power and with the area of calf section.
The short physical performance battery (SPPB) is one of the most valid techniques to mea-
sure physical performance. It consists of a brief set of tests evaluating the functionality of the 
lower limbs. This battery is composed of three different sections. The first one is the assess-
ment of balance in three tests: (a) maintenance of balance in stand position with feet together 
side‐by‐side for 10 seconds; (b) maintenance of balance in semi‐tandem position (heel of one 
foot against side of big toe of the other) for 10”; (c) maintenance of balance in tandem posi-
tion (feet aligned heel to toe) for 10”. The second section evaluates gait speed measuring the 
time required to walk 4 m linear at a normal pace. Finally, the third one measures the time 
required to perform five rises from a chair to an upright position as fast as possible without 
the use of the arms.
Other tests can be used in clinical practice, as they require a very simple execution setting. 
One of these is the sit to stand test, which evaluates the ability to move from sit to stand 
position without using arms. The timed up‐and‐go test (TUG), which evaluates the dynamic 
balance by measuring the time required to complete a series of tasks (getting up from a chair, 
walking a short distance, turning around an obstacle, walking back and sitting down again) 
[20, 21].
Specific mode and intensity of physical activity can act synergistically to maintain and even 
increase muscle mass, strength and power, both in healthy individual and in elderly patients 
with limited functionality. These interventions also have been found effective for all ages and 
there is evidence for similar responses in both female and male [22].
Variable Exams Clinical practice
Muscle mass Computed tomography (CT)
Magnetic resonance imaging (MRI)
Dual energy X‐ray absorptiometry (DXA)
Bioimpedance analysis (BIA)








Physical performance Short Physical Performance Battery (SPPB)
Usual gait speed
Timed up and go test
Stair climb power test
SPP
Usual gait speed
Timed up and go test
Table 3. Measurements of muscle mass, strength and performance in research and clinical practice.
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During aging, a sedentary lifestyle is associated with a decrease in lean body mass and with 
an increase in fat mass, which ultimately leads to an increase in mortality and functional 
limitations. This is demonstrated in studies showing the reduction of cardiovascular‐related 
risk and all causes of mortality in individuals highly physically active than those moderately 
active or worse sedentary.
Physical activity, in particular resistance exercises, is a powerful stimulus to promote muscle 
protein anabolism, resulting in specific metabolic and morphological adaptations of the skel-
etal muscle tissue. Resistance type exercise training can effectively increase muscle strength 
and muscle mass, thus improving physical performance and functional capacity. To stimulate 
muscle hypertrophy and to increase strength in elderly patients, it is known [23] that the tra-
ditional exercise of resistance at low speed (i.e. performing concentric and eccentric to each 
muscle in 2–3”) is found to be a type of intervention that is safe, feasible and effective. The 
physiological response to resistance exercises may consist in an increase in protein synthesis, 
in an activation and proliferation of satellite cells, in a production of anabolic hormones and 
in a decreased activity of catabolic cytokines. Resistance exercises in elderly subjects appear 
to lead to an increased number of mitochondria and a reduction in oxidative stress. Recent 
scientific evidences suggest that muscle performance is a determining factor regarding the 
functional capabilities. A new and effective approach to increase power in elderly subjects is 
found to be the fast‐contraction‐velocity exercise. In addition, the aerobic exercise can gener-
ate benefits on elderly muscles through an increment in mitochondrial energy production, 
increased insulin sensitivity and/or reduction of the oxidative stress [24].
In elderly patients, the clinical relevance of a nutritional and rehabilitative intervention based 
on exercise, resides with the long‐term effects on not only strength and muscle mass but also 
on the implications concerning functional capacity and risk of developing chronic metabolic 
diseases. It is well known that the ability to respond to an anabolic stimulus, through the acti-
vation of muscle protein synthesis, is kept up even in elderly (though to a lesser extent) [24]. 
Definitely, it is possible to affirm that resistance‐type exercise interventions have been shown 
effective in increasing skeletal muscle mass, training muscle strength and/or improving func-
tional capacity in elderly [24].
3. Rehabilitation
3.1. Scientific researches
Over the years, we have therefore investigated the effects of exercise and mechanical stimula-
tion in primary prevention and treatment of sarcopenia.
In 2006, the first study [25] evaluated the selective development of muscle strength in 20 female 
subjects with severe atrophy of the femoral quadriceps muscle, with a mean age of 31 years. 
Subjects were randomly divided in two groups, named A and B. Group A performed 10 reha-
bilitation sessions, 5 times per week, lasting 10 minutes each, with mechano‐sound vibration 
(without performing voluntary contraction) with a defined frequency of 300 Hz. Group B 
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performed 10 sessions of strengthening every other day through isokinetic Cybex equipment 
at 90°/second in concentric‐eccentric mode. The evaluation was performed at first visit (T0), 
after the treatment period (T1) and at a 6 months follow‐up (T2) by isokinetic testing (Cybex) 
with flexion‐extension movement of right and left knee at 180 and 60°/second, in both study 
groups. At T1 evaluation, it was found in both groups a significant increase in muscle strength 
and working ability as well as an improvement in muscular coordination. The increase in 
contractile strength in group A was comparable to that obtained with a conventional rehabili-
tation protocol (group B). Differences between the two groups were the longest duration of 
treatment effectiveness (about 6 months) and the faster achievement of these results, already 
during the protocol, in Group A. High speed contractile improvements induced by the local 
vibrational method appeared more effective; in fact, in group A, contralateral muscle strength 
improved too, unlike the group B.
In a 2008 study, we compared the efficacy of three methods of training in elderly subjects with 
postural instability and sarcopenia [26]. Nineteen subjects (11F and 8M, aged between 64 and 
80 years) took part in the study. Evaluations at T0 and T1 have been carried out through clini-
cal examination, needle biopsy of the vastus lateralis muscle (measuring specific development 
of the individual fibres), expression of myosin heavy chains, transcriptional and regenerative 
capacity profile of satellite cells. Subjects were divided randomly into three groups of six 
subjects each; group A performed aerobic training (endurance), group B anaerobic training 
(power), group C mechano‐sound vibration at a frequency of 300 Hz. The protocol frequency 
was three sessions per week for all study groups. The results obtained showed that the devel-
opment of single fibre strength did not change in any of the training protocols; gene expres-
sion profiles showed, for each type of intervention, the stimulation of a specific metabolic 
pathway, as both resistance and vibration training increased aerobic metabolism, while resis-
tance training stimulated creatine metabolism. All trainings protocols stimulated in a differ-
ent way the expression of sarcomeric and cytoskeletal proteins; in particular, mechano‐sound 
vibration training has stimulated proteins associated with the Z‐line. It was also found that 
satellite cells contribute to regeneration and trophism of muscle fibre. The results therefore 
suggested that all training protocols are effective in contrasting the progression of sarcopenia 
and each one is able to stimulate specific molecular signals. The effects are specific because 
there is a relationship between the type of exercise and the metabolism stimulated.
In another study, we further evaluated the effect of focused vibration on elderly skele-
tal muscle [27]. Eleven subjects (5F and 4M, aged between 65 and 82 years), diagnosed 
with sarcopenia in accordance with the guidelines of the Centers for Disease Control and 
Prevention (CDC) were evaluated and treated. Inclusion criteria for the study were patients 
older than 18 years, diagnosis of sarcopenia in absence of joint pathology. Exclusion criteria 
were cardiovascular and/or metabolic diseases, hereditary or acquired muscular disorders, 
respiratory and psychiatric disorders, treatment with testosterone or other drugs affecting 
muscle mass. Mechanical vibrations were applied at local level at a frequency of 300 Hz on 
thigh muscles for a period of 12 weeks, starting from a 15‐minute per session once a week 
to progressively reach 3 sessions per week. The evaluation consisted of clinical examina-
tion, resting ECG and isometric tests. These were carried out the week before the beginning 
of the study (T0, pre‐session), at the end of the therapeutic protocol (T1, post‐session) and 
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16 weeks after the end of treatment (T2, follow‐up). Moreover, it was evaluated the body 
mass index (BMI), the measurement of the circumference of proximal and distal thigh and 
it was performed the vastus lateralis muscle biopsy. Maximal isometric strength evalua-
tion of lower limb extensor muscles showed an increase in strength since 4 weeks of treat-
ment in women and after 8 weeks in men; increasing strength reached a plateau phase at 
week 12. As it regards the circumferences, it was found a significant increase of the distal 
circumference of 0.5–3 cm and a non‐significant increase of the thigh circumference at the 
proximal zone. Vastus lateralis biopsy results showed the increase of muscle fibre section 
width (T0: 3667 ± 310.7, T1: 4238 ± 357.4 μm2); changing in myosin chains, which switched 
from the isoform slow (MyHC‐1) to the isoform fast (MyHC‐2X). Other interesting observa-
tions were the stimulation of genes involved in energetic metabolism (PIK3R3; GSK‐3), in 
protein synthesis and degradation, in calcium homeostasis (ACTA2; MLCB; ARL5A; LCCP; 
TTID; POP3; RyR3; CHERP) and in oxidative stress processes (P12; PRDX3; MSRA). It was 
also found a down‐regulation of the gene coding for nitric oxide synthase (NOS‐1). The 
results showed that sarcopenic skeletal muscle reduced metabolic power because of sev-
eral factors, such as a reduction in blood supply, fibrosis processes and atrophy develop-
ment. Muscle tissue undergoes continuous oxidative phenomena; this leads to imbalance 
between oxidant and antioxidant capacity; in fact, in elderly, several genes coding for anti-
oxidant factors are down‐regulated. The reduced expression of NOS leads to a reduction 
of the amount of nitric oxide circulating, compromising vasodilatation. Therefore, focused 
mechano‐sound vibration, increasing the expression of genes coding for antioxidant fac-
tors, while enhancing the maximal isometric force, can be considered effective in combat-
ing sarcopenia.
In a more recent study of 2013, we compared the effectiveness of three types of training on 
strength and balance ability on a population of elderly male subjects suffering from sarco-
penia [4]. In this study, 40 male subjects (mean age 71 years) diagnosed with sarcopenia, in 
accordance with the guidelines of the CDC, were evaluated and treated. Inclusion criteria 
of the study were patients over 18 years, sarcopenia diagnosis in absence of joint disorders. 
Exclusion criteria were cardiovascular or metabolic diseases, hereditary or acquired muscular 
disorders, respiratory and psychiatric disorders, treatment with testosterone or other sub-
stances affecting muscle mass. Forty participants were included randomly into one of the four 
study groups. Each group performs a specific protocol. Group A carried out a comprehensive 
sensorimotor training on I‐Moove® with ‘Reebost’ program (for balance and flexibility) for 
20 minutes, after warming‐up with cycle‐ergometer (5 minutes) and stretching of the lower 
limbs; frequency of sessions was 2 times per week for 12 weeks. Group B performed aerobic 
endurance training with leg‐press and leg‐extension: 2 times a week for 12 weeks. Group C 
underwent training vibration with a frequency of 300 Hz (average size of the transducer of 
23.7 cm2) lasting 15 minutes per session, 1 session a week for the first 8 weeks and 3 sessions 
per week in the last four weeks; group D (control group) did not perform any kind of rehabili-
tation program. The assessment was carried out using clinical examination, maximal isometric 
tests performed on leg‐extension equipped with load cell, BMI measurement, gait analysis, 
stabilometry. At the end of treatment was highlighted statistically significant increase in bilat-
eral isometric force equal to 45% in group B (which performed resistance training) and 43% 
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in group C, which was treated with mechano‐sound vibrations. In the group, which carried 
out the sensorimotor training on I‐Moove (group A), the improvement was only 15%, while 
no change was observed in the control group. About balance and stability, it was found a 
significative improvement of the sway area and path length, measured by stabilometry, in 
groups A and C; no improvements were found in groups B and D. Another observation was 
the increase in half‐step length in all three trained groups (108% in group A, 65% in group B, 
92% in group C); step width increased only in the I‐Moove group. Significant reduction of 24% 
in time of contact to the ground was observed only in the vibration training group. The study 
showed that an overall sensorimotor stimulation produced by focused acoustic vibration and 
proprioceptive training, carried out with I‐Moove, is an effective approach to increase strength 
and balance in sarcopenic elderly, which could result in a better quality of life.
As a part of primary prevention, we also evaluated the influence of exercise and focused 
acoustic vibration on blood concentration of some hormones [28]. Aim of the study was to 
evaluate the effects of focused acoustic vibrations, set to a frequency of 300 Hz, on muscle 
performance and blood hormone concentrations in healthy young adult males in acute and 
long‐term observations. In this study, 36 male patients (average age 21.5 years) were evalu-
ated and treated; they usually performed moderate intensity level of physical activity (1–2 
times per week). The participants were divided into 2 groups: group A performed focused 
mechano‐acoustic vibrations every 3 days for 4 weeks (10 sessions overall); instead, group B 
performed resistance training every 3 days for 4 weeks (10 sessions). The assessment was car-
ried out every 3 days, during therapeutic session, through haematochemical parameters (to 
quantify hormone levels), counter‐movement jump (CMJ) and maximal voluntary isometric 
contraction (MVC); assessments were performed before each session, immediately after it 
and 1 hour after the end of treatment. All subjects also performed isokinetic and MVC tests 
after 4 weeks of training and at 2 months follow‐up. Group A showed a significant increase 
in growth hormone (GH) and creatine‐phosphokinase levels and a reduction of cortisol levels 
(P < 0.05); no change was highlighted in group B. In both groups, it was observed a significant 
improvement in MVC test (P < 0.05). After 4 weeks, the results showed evidence of an increase 
in isokinetic tests and in maximal strength test in both groups; the improvement persisted in 
the next 2 months. These results indicate that focused mechano‐acoustic vibrations can influ-
ence the concentration of particular hormones and can improve neuromuscular performance. 
The benefit gained is maintained over the medium to long term and it was comparable to 
what happens after a resistance training treatment.
Other authors have also studied the effectiveness of vibration therapy in improving strength 
and muscle tone in patients suffering from sarcopenia. Wei et al. [29] try to determine the 
optimal combination of frequency and exposure time of a whole‐body vibration (WBV) train-
ing program to improve muscle performance in elderly with age‐related muscle loss. A total 
of 80 community‐dwelling older adults with sarcopenia were randomly divided into four 
groups, 20 patients each: first group treated with WBV set to low‐frequency and long duration 
(20  Hz  × 720  seconds), second group treated at medium‐frequency and medium duration (40  Hz  × 
360 seconds), third group set to high‐frequency and short duration (60  Hz  ×  240  seconds) 
and control group did not perform any training. The treatment period lasted 12 weeks and 
a follow‐up was scheduled at additional 12 weeks. There was a significant time per group 
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interaction effect in isokinetic knee extension at 180°/second. The study found significant time 
effects in all muscle strength outcome variables. Comparing second group (WBV set at 40 Hz 
for 360 seconds) with control group, the authors found that the percentage of change from 
baseline values were significant on isokinetic knee extension tests (at 180 and 60°/second). 
Therefore, they concluded that the best combination for WBV exercise is to set medium fre-
quency and medium duration (40  Hz  × 360  seconds), because of it shows the best outcome 
among all other combinations tested; moreover, the improvements in knee extension perfor-
mance can be maintained for 12 weeks after cessation of WBV training.
The effectiveness of electrostimulation in rehabilitation has been long known, especially in 
muscle strengthening. Kern et al [30] analysed (at functional, structural and molecular level) 
the effects of electrical stimulation training on healthy seniors with normal lifestyle, without 
routine sport activity. The study found that electrical stimulation was able to improve muscle 
torque and functional performances and it increased muscle fibres and most importantly fast 
fibres, which are related to the power of skeletal muscle. At molecular level, electrical stimula-
tion induced up‐regulation of insulin‐like growth factor 1 (IGF‐1) and modulation of MuRF‐1, 
a muscle‐specific atrophy‐related gene. Furthermore, it induced up‐regulation of relevant 
markers of differentiating satellite cells and of extracellular matrix remodelling, which might 
guarantee shape and mechanical forces of trained skeletal muscle as well as maintenance of 
satellite cell function, reducing fibrosis. This study provide evidence that electrostimulation 
is a safe method to counteract muscle decline associated with aging.
In 2015, Barberi et al. [31] analysed some downstream pathways activated by IGF‐1. They 
demonstrated that electrical stimulation increases not only anabolic pathways, but it also 
reduces muscle catabolism. Extracellular matrix during physical exercise shows remodel-
ling processes. The authors demonstrated that this occur also with electrostimulation, due 
to enhance of collagen expression; in fact, they observed an up‐regulation of three differ-
ent forms of collagen (I, III and VI) in electrical stimulated muscle. The question was if this 
increase in collagen was due to stimulated fibrosis by electrical stimulation. However, biopsy 
did not demonstrate any accumulation of fibrotic tissue. Further supporting the morphologi-
cal evidences, Barberi et al. analysed miR29, one of the most important controllers of fibro-
sis. Actually, the electrical stimulation regulates miR29, which might down‐regulate fibrosis. 
Then authors verified electrical stimulation in increasing activity of satellite cells, such as 
physical exercise. In fact, electrostimulation increased the number of these cells, and this 
is also demonstrated by the increase of their molecular markers (myogenin, miR‐206 and 
miR‐1). In conclusion, the electrical stimulation can be applied to elderly sarcopenic patients, 
which might not carry out normal physical activity, modulating similar factors associated 
with exercise. In particular, IGF‐1 once stimulated through electrostimulation, activates ana-
bolic pathway, increasing protein synthesis and satellite cells. All these modifications lead to 
an increase in muscle performance.
As part of a bio‐progressive rehabilitative approach, treatment of sarcopenic patients may not 
be limited to muscle strengthening or pain resolution. It appears clear; therefore, the need 
for a global approach to the patient, which also guarantees postural and gait rehabilitation. 
To do this, we usually consider the use of SPAD® (dynamic anti‐gravitary postural system), 
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the function of which is to provide postural stability and to increase exteroceptive and pro-
prioceptive sensitivity. SPAD® [32] is composed by a conveyor belt, surmounted by a lifting 
structure, which forces the patient to walk in a straight line on a treadmill, while six proprio-
ceptive blocks (four anterior and two on the back) act on the rotation components.
In a 2008 study [33], the aim was to define the possibility of using SPAD system in elderly 
rehabilitation. Group A was treated with SPAD system, while group B performed a proprio-
ceptive rehabilitative protocol on Galileo platform (WBV at 28 Hz). Patients were evaluated 
at the beginning of the treatment (T0), at the end (T1) and at 6 months follow‐up (T2) through 
gait analysis, stabilometry and isokinetic test (Cybex® system). After treatment period, both 
groups showed a significative improvement in gait alignment, a reduction of sway area and 
ellipse surface in stabilometry and a significative improvement in isokinetic tests. At follow‐
up evaluation, better results were found in group A (maintenance of previous results) than 
in group B, especially in gait and balance. These results show the effectiveness of both treat-
ments suggested, with a better outcome at follow‐up in the group that performed a rehabilita-
tive protocol with SPAD system. In conclusion, it can be stated that SPAD treatment allows 
to comprehensively address the problem of postural disability evident in aging, as it acts on 
deep spine muscles, improving lower limb muscles tone and associating a motor‐vestibular 
rehabilitation. This means a greater capacity of mobility with a better quality of life for elderly 
people.
3.2. Rehabilitative protocols
Scientific data illustrated above and those collected by our personal experience allowed us to 
summarise that each type of physical agents in medicine has a proper applicability in terms of 
cost/benefit ratio. To modulate muscle activity, enhancing muscle tone, the approach applied is:
Step 1. Focused mechano‐acoustic vibrations
Step 2. Focused mechano‐acoustic vibrations + SPAD
Step 3. Electrical stimulation + whole‐body vibrations + SPAD
With regard to the focused mechano‐acoustic vibration, the frequencies related to effects on 
muscles can be schematically summarised as follows:
• 120 Hz, muscle relaxation
• 200 Hz, strengthening of slow muscle fibres
• 300 Hz, strengthening of fast muscle fibres
Therefore, the treatment protocol we recommend, using Vibration Sound System®, in elderly 
patients suffering from sarcopenia, consists of 200 Hz for 10 minutes, 300 Hz for 10 minutes 
and 120 Hz for 5 minutes, applied with segmental strips in standing and/or supine position 
(Figure 2). The aim of this treatment is muscle strengthening and corticalisation.
Integrated protocols involve the use of focal vibrations in combination with active exercises 
and systems that increase proprioceptive stimulation to determine the synergy between  stimuli. 
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For example, if the clinical conditions of the patient permit it, we work with Vibration Sound 
System® to carry out eccentric exercises in upright position.
Treatment goals include increased strength through muscle hypertrophy and improved 
flexibility. This is also achieved through stretching exercises that improve the absorption of 
energy and the muscular movement range, and thus the power. Therefore, the reduction of 
the risk of falling, as well as the improvement of coordination, is achieved.
Another type of integrated protocol, to recover kinetic and kinematic characteristics of gait, 
includes the use of Vibration Sound System® with a proprioceptive system called Synergy Mat 
(Human Tecar® Unibell srl, Calco, Italy). It is composed by mats and pillows and it allows train-
ing, rehabilitation and natural and harmonious re‐education of the body. Different surfaces 
give the possibility to work barefoot on different levels of instability, responding to the needs 
of personalised training and rehabilitation (Figure 3). Different densities correspond to dif-
ferent level of movement absorption, providing protection of the joints and increasing energy 
expenditure time. The variety of interchangeable elements that composed the Synergy Mat set 
(mats and pillows) provides many combinations of routes adapted to the user‐specific needs.
To better understand the potential of vibrations and even the feasibility to integrate them with 
other rehabilitative systems (such as synergy mat), Table 4 provides a list of protocols related 
to specific objectives and a brief description of exercises.
Figure 2. Focused mechano‐acoustic vibrations, in supine position.
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As mentioned, the second‐line treatment we suggest for sarcopenia is the association of 
focused mechano‐acoustic vibrations with SPAD® (Figure 4). This system has two alternative 
and complementary support systems: pneumatic and mechanical, which allow using con-
sistently rates of body weight support even higher than 50%. The aim of this therapy is the 
recruitment of specific muscle chains, postural reprogramming and optimisation of motor 
coordination with restoration of the proprioceptive stimuli and physiological recovery of gait 
motor patterns. Therefore, the goals are both mechanical (partial decompression of lumbar 
spinal structures during the walk due to the microgravitary environment created) and pro-
prioceptive (automatic‐induced adaptations related to walking, once the mechanical action of 
relieves has achieved the percentage of body weight support established).
Figure 3. Another possible way to use focused mechano‐acoustic vibrations in association with synergy mat.
Aim Frequencies Description
Muscle relaxation 50–120 Hz for 10 minutes  
(applied with an hand piece)
Treatment of tender points and 
fatigue
120–200 Hz for 10 minutes  
(applied with an hand piece)
Treatment of trigger points and taut 
bands
Muscle strengthening,  
upright position
200 Hz for 10 minutes
300 Hz for 10 minutes
120 Hz for 5 minutes
(applied with segmental strips)
Strengthening of slow muscle fibres
Strengthening of fast muscle fibres
Deconditioning
Muscle strengthening and 
corticalisation
200 Hz for 10 minutes
300 Hz for 10 minutes
120 Hz for 5 minutes
(applied with segmental strips)
Working with squats through active 
work or isometric muscle contraction
Proprioceptive exercise in 
combination with Synergy Mat 
(Human Tecar® Unibell srl, 
Calco, Italy)
60–80–100–120–140–160–180–200–220– 
240–260–280–300 Hz, to increase every  
2 minutes
(applied with segmental strips)
Mono‐ and bipedal walking on 
unstable proprioceptive platforms
Table 4. Treatment protocols proposed using mechano‐acoustic vibrations.
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Third‐line treatment consists of whole‐body vibrations, electrical stimulation and SPAD.
Currently available WBV devices (Figure 5) deliver vibrations at a range of frequencies from 
15 to 60 Hz and displacements from <1 to 10 mm. Considering several combinations of ampli-
tudes and frequencies with current technology, it is clear that there are a wide variety of 
WBV protocols that could be used in elderly patients suffering from sarcopenia. The duration 
of treatment varies between individuals as well as frequencies (range 15–45 Hz); moreover, 
sessions of short duration (2–20 minutes), interspersed in variable‐duration periods of rest, 
are recommended. The exercise on WBV platform would have to be performed in standing 
with hips and knees in slight flexion, to ensure better transmissibility of the forces to hips and 
spine. Table 5 shows our WBV protocols to treat sarcopenia.
Neuromuscular electrical stimulation is defined as the use of electrical stimulation to acti-
vate muscles through intact peripheral nerve. Conventional exercise programs to increase 
strength are based on the overload principle of eliciting a small number of contractions of 
high‐intensity (at least 70% of a maximal contraction 3–10 repetitions or fewer) in a treat-
ment session performed 3–5 times per week. The same frequency of sessions can be applied 
when using electrical stimulation to increase strength in healthy and healthy‐but‐injured 
patients.
Our therapeutical approach involves the use of alternating currents of medium frequency 
produced by Horizontal Therapy (Hakomed®, Figure 6). The rationale is that each induced 
frequency generates a specific effect; for strengthening, in example, the frequencies at which 
muscles have to work are 20 or 100 Hz. In particular, our protocol for sarcopenia consists of 
a stimulation at 20 Hz for 30 minutes per session; this program includes a stimulation phase 
and a rest phase of 30 seconds each.
Figure 4. SPAD® system.




Strength training Frequency: 15–12 Hz.
Duration: 3–5 minutes.
Amplitude: medium to high, 
depending on comfort.
Starting position: exercises out of force and power 
series alternately.
Sets of 10, three sets per exercise. 10‐to‐20‐second rest 
between sets.
1–3‐minute rest between the sets.





Duration: 3–5 minutes for each 
exercise.
Amplitude: low to medium.
Starting position: in standing, carry out exercises 
from balance and stretching series.
The number of repetitions is individually tailored. 
Importantly, the whole body is gradually brought to 
an end‐of‐range stretching position.
Balance: placing one foot alternately on the lowest 
position, slightly lift the other foot and hold at 5 Hz 
without support for 5–30 seconds.
Power training Frequency: 18–30 Hz.
Duration: 5–6 minutes.
Amplitude: medium to high.
Carry out exercises without weights, concentrating 
on speed and changes in direction.
Table 5. Treatment sequence for the use of whole‐body vibration in sarcopenia.
Figure 5. Whole‐body vibrations (WBV).
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4. Conclusions
Sarcopenia is a complex problem and an important emerging field in rehabilitation of elderly. 
The progressive and generalised loss of skeletal muscle mass and strength is associated with 
the risk of physical disability, poor quality of life and death.
For these reasons, adopting the correct therapeutic solutions results of fundamental impor-
tance; to do this is necessary to know, not only the possible pharmacological interventions, 
but also the therapeutic possibilities that can be used thanks to the increased knowledge in 
the field of physical therapy. The role of rehabilitation specialist must be to integrate various 
therapeutic options in order to set a more suitable rehabilitative approach with the purpose 
of recovery postural assessment and amplify sensory‐motor systems.
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